POCT market seen reaching $86.91 billion by 2030

The point-of-care testing market is projected to rise from $50.79 billion in 2025 to $56.68 billion in 2026, with growth expected to continue to $86.91 billion by 2030. Telemedicine adoption, home testing, and faster diagnostics are among the main forces shaping the market’s next phase.

Why it matters: - Point-of-care testing gives clinicians faster results at the patient’s side, which can speed treatment decisions and improve outcomes. - The market’s growth reflects demand for quicker diagnostics as healthcare shifts toward remote care, decentralized services, and self-testing. - Telemedicine depends on timely test results that can be shared with remote providers, making POCT a key enabler of virtual care.

What happened: - The Business Research Company released its Point-Of-Care-Testing (POCT) Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Aug. 25, 2026. - The report estimates the POCT market reached $50.79 billion in 2025 and will grow to $56.68 billion in 2026. - The report projects the market will reach $86.91 billion by 2030. - North America held the largest share of the global POCT market in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - POCT means performing diagnostic tests at or near the site of patient care. - POCT is designed to deliver immediate results for faster clinical decision-making. - The historical growth rate from 2025 to 2026 is 11.6%. - The forecast CAGR from 2026 to 2030 is 11.3%. - Growth drivers include rising chronic disease rates, more emergency and critical care use, limited access to centralized labs and demand for immediate diagnostic results. - Future growth is expected to be supported by device miniaturization, home care, remote patient monitoring, infectious disease outbreaks, healthcare decentralization and self-testing diagnostics. - Emerging trends include wider use of rapid diagnostic testing at the point of care, more home-based and self-testing options, broader availability of over-the-counter diagnostic products, earlier disease screening and improved accuracy and sensitivity. - The report’s 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies, future trend analysis and updated graphics and tables. - The report is available as a free sample and as the full market report.

Between the lines: - The forecast shows POCT moving from a niche diagnostic tool toward a core part of distributed healthcare. - Telemedicine and POCT are becoming more connected, because virtual visits still need reliable test data to guide care. - North America’s lead suggests mature adoption, while Asia-Pacific’s faster growth points to broader expansion in newer and scaling healthcare systems. - The report highlights a shift from clinic-based testing toward consumer-facing diagnostics and home use.

What's next: - The market is expected to keep expanding as healthcare providers adopt faster, smaller and more portable diagnostic tools. - Growth likely will track continued telehealth use, more home monitoring and wider acceptance of self-testing. - The Business Research Company is offering further access through its sample report and full report pages.

The bottom line: - POCT is set for steady double-digit growth, with telemedicine, home testing and faster diagnosis driving demand across global healthcare systems.